Posttranscriptional regulatory elements enhance antigen expression and DNA vaccine efficacy

DNA and Cell Biology

Volumn 28, Issue 5, 2009, Pages 233-240

  Sun, Jing ^a,b   Li, Dingfeng ^b   Hao, Yanling ^b   Zhang, Yuwei ^b   Fan, Wenling ^b   Fu, Jingjing ^b   Hu, Yunzhang ^a   Liu, Yong ^b   Shao, Yiming ^b  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAG PROTEIN; PLASMID DNA; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEINS, CYTOMEGALOVIRUS; IMMEDIATE-EARLY PROTEINS, CYTOMEGALOVIRUS; MESSENGER RNA; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; EMBRYO; FEMALE; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HEPATITIS B VIRUS; HEPATITIS VIRUS; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTRON; LOW DRUG DOSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CELL CULTURE; GENETIC TRANSFECTION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; METABOLISM; PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA PROCESSING; VACCINATION; WESTERN BLOTTING;

ANIMALIA; EUKARYOTA; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS 1; MUS; WOODCHUCK HEPATITIS VIRUS;

AIDS VACCINES; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; GENE PRODUCTS, GAG; HEPATITIS B VIRUS; HEPATITIS B VIRUS, WOODCHUCK; HIV-1; HUMANS; IMMEDIATE-EARLY PROTEINS; INTRONS; MICE; MICE, INBRED BALB C; PLASMIDS; REGULATORY SEQUENCES, NUCLEIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TRANSFECTION; VACCINATION; VACCINES, DNA;

EID: 65549087977     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2009.0862     Document Type: Article

References (40)

1. Callendret, B., Lorin, V., Charneau, P., Marianneau, P., Contamin, H., Betton, J.M., van der Werf, S., and Escriou, N. (2007). Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS. Virology 363, 288-302. (Pubitemid 46764943)
2. Chapman, B.S., Thayer, R.M., Vincent, K.A., and Haigwood, N.L. (1991). Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells. Nucleic Acids Res 19, 3979-3986. (Pubitemid 21912770)
3. Donello, J.E., Loeb, J.E., and Hope, T.J. (1998). Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J Virol 72, 5085-5092. (Pubitemid 28215689)
4. Donnelly, J.J., Ulmer, J.B., Shiver, J.W., and Liu, M.A. (1997). DNA vaccines. Annu Rev Immunol 15, 617-648. (Pubitemid 27169294)
5. Fuller, D.H., Loudon, P., and Schrnaljohn, C. (2006). Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases. Methods 40, 86-97. (Pubitemid 44419542)
6. Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C., and Robinson, H.L. (1993). DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90, 11478-11482. (Pubitemid 23971055)
7. Garg, S., Oran, A.E., Hon, H., and Jacob, J. (2004). The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines. J Immunol 173, 550-558. (Pubitemid 38797383)
8. Garmory, H.S., Brown, K.A., and Titball, R.W. (2003). DNA vaccines: improving expression of antigens. Genet Vaccines Ther 1, 1-5.
9. Gruh, I., Wunderlich, S., Winkler, M., Schwanke, K, Heinke, J., Blomer, U., Ruhparwar, A., Rohde, B., Li, R.K., Haverich, A., and Martin, U. (2008). Human CMV immediate-early enhancer: a useful tool to enhance cell-type-specific expression from lentiviral vectors. J Gene Med 10, 21-32.
10. Guang, S., and Mertz, J.E. (2005). Pre-mRNA processing enhancer (PPE) elements from intronless genes play additional roles in mRNA biogenesis than do ones from intron-containing genes. Nucleic Acids Res 33, 2215-2226. (Pubitemid 41439890)
11. Gurunathan, S Klinman, D.M., and Seder, R.A. (2000). DNA vaccines: immunology application, and optimization. Annu Rev Immunol 18, 927-974. (Pubitemid 30365401)
12. Hadzopoulou-Cladaras, M., Felber, B.K., Cladaras, C., Atha- nassopoulos, A., Tse, A., and Pavlakis, G.N. (1989). The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the Env region. J Virol 63, 1265-1274. (Pubitemid 19061368)
13. Hammarskjold, M.L., Heimer, J., Hammarskjold, B., Sangwan, I., Albert, L., and Rekosh, D. (1989). Regulation of human immunodeficiency virus Env expression by the rev gene product. J Virol 63, 1959-1966. (Pubitemid 19107791)
14. Heise, T., Sommer, G., Reumann, K., Meyer, I., Will, H., and Schaal, H. (2006). The hepatitis B virus PRE contains a splicing regulatory element. Nucleic Acids Res 34, 353-363. (Pubitemid 43160058)
15. Huang, J., and Liang, T.J. (1993). A novel hepatitis B virus (HBV) genetic element with Rev response element-like properties that is essential for expression of HBV gene products. Mol Cell Biol 13, 7476-7486. (Pubitemid 23354272)
16. Huang, M.T., and Gorman, C.M. (1990). Intervening sequences increase efficiency of RNA 3' processing and accumulation of cytoplasmic RNA. Nucleic Acids Res 18, 937-947. (Pubitemid 20089463)
17. Huang, Z.M., and Yen, T.S. (1995). Role of the hepatitis B virus posttran-scriptional regulatory element in export of intronless transcripts. Mol Cell Biol 15, 3864-3869.
18. Klein, R., Ruttkowski, B., Knapp, E., Salmons, B., Gtinzburg, W.H., and Hohenadl, C. (2006). WPRE-mediated enhancement of gene expression is promoter and cell line specific. Gene 372, 153-161.
19. Le Hir, H., Nott, A., and Moore, M.J. (2003). How introns influence and enhance eukaryotic gene expression. Trends Biochem Sci 28, 215-220. (Pubitemid 36507161)
20. Li, D., Liu, Y., Zhang, Y., Xu, J., Hong, K., Sun, M., and Shao, Y. (2007). Adjuvant effects of plasmid-generated hairpin RNA molecules on DNA vaccination. Vaccine 25, 6992-7000. (Pubitemid 47391095)
21. Lori, F., Weiner, D.B., Calarota, S.A., Kelly, L.M., and Lisziewicz, J. (2006). Cytokine-adjuvanted HIV-DNA vaccination strategies. Springer Semin Immunopathol 28, 231-238.
22. Lu, S., and Cullen, B.R. (2003). Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells. RNA 9, 618-630. (Pubitemid 36505459)
23. Lu, S., Wang, S., and Grimes-Serrano, J.M. (2008). Current progress of DNA vaccine studies in humans. Expert Rev Vaccines 7, 175-191.
24. Luckay, A., Sidhu, M.K., Kjeken, R., Megati, S., Chong, S.Y., Roopchand, V., Garcia-Hand, D., Abdullah, R., Braun, R., Montefiori, D.C., Rosati, VI., Felber, B.K., Pavlakis, G.N., Ma- thiesen, I., Israel, Z.R., Eldridge, J.H., and Egan, M.A. (2007). Effect of plasmid DNA vaccine design and in vivo electro- poration on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81, 5257-5269. (Pubitemid 46744435)
25. Mahonen, A.J., Airenne, K.J., Purola, S., Peltomaa, E., Kaikkonen, M.U., Riekkinen, M.S., Heikura, T., Kirmunen, K, Roschier, M.M., Wirth, T., and Yla-Herttuala, S. (2007). Posttranscrip- tional regulatory element boosts baculovirus-mediated gene expression in vertebrate cells. J Biotechnol 131,1-8. (Pubitemid 47042932)
26. Norman, J.A., Hobart, P., Manthorpe, M., Feigner, P., and Wheeler, C. (1997). Development of improved vectors for DNA-based immunization and other gene therapy applications. Vaccine 15, 801-803. (Pubitemid 27287960)
27. Nott, A., Meislin, S.H., and Moore, M.J. (2003). A quantitative analysis of intron effects on mammalian gene expression. RNA 9, 607-617. (Pubitemid 36505458)
28. Pertl, U., Wodrich, H., Ruehlmann, J.M., Gillies, S.D., Lode, H.N., and Reisfeld, R.A. (2003). Immunotherapy with a post- transcriptionally modified DNA vaccine induces complete protection against metastatic neuroblastoma. Blood 101, 649-654. (Pubitemid 36077589)
29. Popa, I., Harris, M.E., Donello, J.E., and Hope, T.J. (2002). CRM1- dependent function of a cis-acting RNA export element. Mol Cell Biol 22, 2057-2067. (Pubitemid 34224614)
30. Roth, J., and Dobbelstein, M. (1997). Export of hepatitis B virus RNA on a Rev-like pathway: inhibition by the regenerating liver inhibitory factor IkappaB alpha. J Virol 71, 8933-8939. (Pubitemid 27446486)
31. Schwartz, S., Felber, B.K., and Pavlakis, G.N. (1992). Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J Virol 66, 150-159.
32. Sharpe, M., Lynch, D., Topham, S., Major, D., Wood, J., and Loudon, P. (2007). Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine 25, 6392-6398. (Pubitemid 47090232)
33. Tsang, C., Babiuk, S., van Drunen Littel-van den Hurk, S., Ba- biuk, L.A., and Griebel, P. (2007). A single DNA immunization in combination with electroporation prolongs the primary immune response and maintains immune memory for six months. Vaccine 25, 5485-5494. (Pubitemid 47039264)
34. Tsen, S.W., Paik, A.H., Hung, C.F., and Wu, T.C. (2007). Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells. Expert Rev Vaccines 6, 227-239. (Pubitemid 46607458)
35. Wang, S., Farfan-Arribas, D.J., Shen, S., Chou, T.H., Hirsch, A., He, V., and Lu, S. (2006). Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine 24, 4531-4540. (Pubitemid 43776774)
36. Wolff, J.A., Ludfke, J.J., Acsadi, G., Williams, P., and Jani, A, (1992). Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1,363-369.
37. Wolff, J.A., Malone, R.W., Williams, P., Chong, W Acsadi, G., Jani, A., and Feigner, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468. (Pubitemid 20145055)
38. Xu, Z.L., Mizuguchi, H., Ishii-Watabe, A., Uchida, E., Mayumi, T., and Hayakawa, T. (2001). Optimization of transcriptional regulatory elements for constructing plasmid vectors. Gene 272, 149-156. (Pubitemid 32695407)
39. Xu, Z.L., Mizuguchi, H., Mayumi, T., and Hayakawa, T. (2003). Woodchuck hepatitis virus posttranscriptional regulation element enhances transgene expression from adenovirus vectors. Biochim Biophys Acta 1621, 266-271. (Pubitemid 36638579)
40. Zufferey, R., Donello, J.E., Trono, D., and Hope, T.J. (1999). Woodchuck hepatitis virus posttranscriptional regulator}' element enhances expression of transgenes delivered by retroviral vectors. J Virol 73, 2886-2892. (Pubitemid 29135675)